Rapidly progressive behavioral changes and Parkinsonism in a 68-year-old man

Movement Disorders

Volumn 19, Issue 5, 2004, Pages 534-543

  Kleiner Fisman, Galit ^a   Lang, Anthony E ^a   Bergeron, Catherine ^b   Burn, David J ^c   Paviour, Dominic C ^d  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; VALPROIC ACID;

AGED; AIRWAY OBSTRUCTION; APHASIA; ARTICLE; ATTENTION; BABINSKI REFLEX; BALANCE DISORDER; BEHAVIOR DISORDER; BODY POSTURE; CASE REPORT; DEATH; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; FALLING; GAIT DISORDER; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IRRITABILITY; LABORATORY TEST; MALE; MENTAL INSTABILITY; MICROSCOPY; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MUSCLE SPASM; MYALGIA; MYOCLONUS; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PALLIATIVE THERAPY; PARKINSONISM; PRIORITY JOURNAL; VIDEORECORDING; WALKING; BODY EQUILIBRIUM; BRAIN; CEREBROSPINAL FLUID; CLINICAL OBSERVATION; CLINICAL STUDY; COGNITIVE DEFECT; DEMENTIA; DIAGNOSIS; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; MENTAL DISEASE; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TIME;

AGED; BRAIN; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MOOD DISORDERS; MUSCULOSKELETAL EQUILIBRIUM; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; TIME FACTORS; VIDEOTAPE RECORDING;

EID: 4544314440     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10694     Document Type: Article

References (56)

1. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930.
2. Otto M, Wiltfang J, Cepek L, et al. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002;58:192-197.
3. McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia [review]. Neurol Clinic 2000;18:856-902.
4. Cairns NJ, Perry RH, Jaros E, et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003;341:177-180.
5. Mitchell SL. Extrapyramidal features in Alzheimer's disease. Age Ageing 1999;28:401-409.
6. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
7. Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-770.
8. Arvanitakis Z, Wszolek ZK. Recent advances in the understanding of tau protein and movement disorders. Curr Opin Neurol 2001; 14:491-497.
9. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
10. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-486.
11. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999;53:1969-1974.
12. Garg RK. Subacute sclerosing parrencephalitis. Postgrad Med J 2002;78:63-70.
13. Alafuzoff I, Hartikainen P, Hanninen T, et al. Rapidly progressive multifocal leukoencephalopathy with substantial cell-mediated inflammatory response and with cognitive decline of non-Alzheimer type in a 75-year-old female patient. Clin Neuropathol 1999;18:113-123.
14. Lynch T, Odel J, Fredericks DN, et al. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Ann Neurol 1997;42:120-124.
15. Page NG, Lean JS, Sanders MD. Vertical supranuclear gaze palsy with secondary syphilis. J Neurol Neurosurg Psychiatry 1982;45:86-88.
16. Ferro JM. Vasculitis of the central nervous system. J Neurol 1998;245:766-776.
17. Alrawi A, Trobe JD, Blaivas M, Musch DC. Brain biopsy in primary angiitis of the central nervous system. Neurology 1999; 53:858-860.
18. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123:1481-1494.
19. Saiz A, Graus F, Dalmau J, et al. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999;46:774-777.
20. Rivaud-Pechoux S, Vidailhet M, Gallouedec G, et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 2000;54:1029-1032.
21. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive suprarnuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65-74.
22. Lees AJ. The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). In: Marsden CD, Fahn S, editors. Movement disorders. 2nd ed. Vol. 2. London: Butterworth; 1987. p 272-287.
23. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology 1990;40:1203-1212.
24. Haik S, Brandel JP, Sazdovitch V, et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology 2000;55:1401-1404.
25. Weeks RA, Scaravilli F, Lees AJ, et al. Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome. Mov Disord 2003;18:331-336.
26. Greenberg SM, Vonsattel JP, Stakes JW, et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073-2079.
27. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
28. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996;5:339-350.
29. Mitsuyama Y. Presenile dementia with motor neuron disease. Dementia 1993;4:137-142.
30. Forno LS, Langston JW, Herrick MK, et al. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Acta Neuropathol (Berl) 2002;103:599-606.
31. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999;14:674-680.
32. Grant MP, Cohen M, Petersen RB, et al. Abnormal eye movements in Creutzfeldt-Jakob disease. Ann Neurol 1993;34:192-197.
33. Brandel JP, Delasnerie-Laupretre N, Laplanche JL, et al. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 2000;54:1095-1099.
34. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001;56:1528-1533.
35. Kenney K, Brechtel C, Takahashi H, et al. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 2000;48:395-398.
36. Schroter A, Zerr I, Henkel K, et al. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000;57:1751-1757.
37. Demaerel P, Sciot R, Robberecht W, et al. Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol 2003;250:222-225.
38. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.
39. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000;48:323-329.
40. Collie DA, Sellar RJ, Zeidler M, et al. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001;56:726-739.
41. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003;126:2291-2303.
42. Lemstra AW, van Meegen MT, Vreyling JP, et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 2000;55:514-516.
43. Chapman T, McKeel DW Jr, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:1396-1397.
44. Sackett D, Haynes R, Guyatt G, Tugwell P. The interpretation of diagnostic data. Clinical epidemiology: a basic science for clinical medicine. Philadelphia: Lippincott, Williams and Wilkins; 1991. p 69-170.
45. Munoz DG, Dickson DW, Bergeron C, et al. The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol 2003; 54(Suppl.):24-28.
46. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998;24:104-117.
47. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-418.
48. Bak TH, Hodges JR. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol 2001;248:260-270.
49. Wakabayashi K, Piao YS, Hayashi S, et al. Ubiquitinated neuronal inclusions in the neostriatum in patients with amyotrophic lateral sclerosis with and without dementia - a study of 60 patients 31 to 87 years of age. Clin Neuropathol 2001;20:47-52.
50. Tsuchiya K, Takahashi M, Shiotsu H, et al. Sporadic amyotrophic lateral sclerosis with circumscribed temporal atrophy: a report of an autopsy case without dementia and with ubiquitinated intraneuronal inclusions. Neuropathology 2002;22:308-316.
51. Okamoto K, Hirai S, Yamazaki T, et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 1991;129:233-236.
52. Anderson VE, Cairns NJ, Leigh PN. Involvement of the amygdala, dentate and hippocampus in motor neuron disease. J Neurol Sci 1995;129(Suppl.):75-78.
53. Mackenzie IR, Feldman H. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol (Berl) 2003;105:98-102.
54. Holton JL, Revesz T, Crooks R, Scaravilli F. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl) 2002;103:221-227.
55. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077-1079.
56. Tolnay M, Probst A. Frontotemporal lobar degeneration - tau as a pied piper? Neurogenetics 2002;4:63-75.